DaVita Inc. (NYSE:DVA) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC raised its stake in shares of DaVita Inc. (NYSE:DVA) by 20.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,587 shares of the company’s stock after purchasing an additional 272 shares during the period. GAMMA Investing LLC’s holdings in DaVita were worth $237,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Transcendent Capital Group LLC purchased a new position in shares of DaVita in the 3rd quarter worth $25,000. Blue Trust Inc. raised its holdings in shares of DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after purchasing an additional 119 shares during the period. Quarry LP acquired a new position in shares of DaVita in the 3rd quarter valued at about $60,000. Point72 Hong Kong Ltd purchased a new stake in shares of DaVita during the 2nd quarter worth about $68,000. Finally, Versant Capital Management Inc increased its position in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

DaVita stock opened at $152.73 on Wednesday. DaVita Inc. has a 12-month low of $103.40 and a 12-month high of $169.51. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The company has a market capitalization of $12.52 billion, a price-to-earnings ratio of 16.48, a price-to-earnings-growth ratio of 0.86 and a beta of 0.92. The firm’s fifty day moving average price is $154.88 and its 200 day moving average price is $151.87.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business had revenue of $3.26 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the previous year, the firm posted $2.85 earnings per share. The firm’s revenue was up 4.6% compared to the same quarter last year. On average, research analysts forecast that DaVita Inc. will post 9.71 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on DVA shares. Truist Financial boosted their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Barclays increased their price target on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.